BioSpace News Archive

Innovation, customer satisfaction and loyalty drive sales and growth

Bastian succeeds M2Gen Executive Chair William S. Dalton, M.D., Ph.D., who has served as interim CEO since September 2018.

Ms. Donato will focus on operationalizing and evolving a strategic framework for the organization, while identifying and implementing a range of growth initiatives that will add further value for its customers.

Atreca, Inc.(Nasdaq: BCEL), a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types, today announced the pricing of its initial public offering of 7,350,000 shares of common stock at a price to the public of $17.00 per share.

Industry veterans from Netflix and EA join fastest growing health information brand

Topical Collections offer clinicians convenient access to relevant and current lectures on issues related to today’s leading medical challenges.

Among the first RF home-use devices ever to receive approval; the company is preparing for sales in the US

A next-generation clinical trial program and the first-ever adaptive platform trial for brain cancer, GBM AGILE is a move away from the traditional, one-size-fits-all approach to clinical trials – a major step forward for Precision Medicine.

HempFusion, Inc. (“HempFusion” or the “Company”), a leading US hemp-based cannabidiol (“CBD”) Company with over 30 product SKU’s distributed to over 3,400 retailers, is pleased to announce the closing of brokered and non-brokered private placements of a total of 28,800,000 units of the Company (each, a “Unit”

Inc. magazine revealed today that Rectangle Health is No. 3973 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies